H R Watson

Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study

C. M. Black, L Halkier-Sørensen, J. J. F. Belch et al. · Lara D. Veeken · 1998 · 135 citations · Full text

Medicine, Pharmacotherapy, Hypersensitivity +7

Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.

Neil McHugh, Mary Ellen Csuka, H R Watson et al. · Annals of the Rheumatic Diseases · 1988 · 99 citations

Medicine, Clinical Sciences, Pharmacotherapy +8

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.

H. I. TORLEY, Rajan Madhok, H A Capell et al. · Annals of the Rheumatic Diseases · 1991 · 77 citations

Medicine, Oncology, Ophthalmology +10

Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis.

H R Watson, Richard M. Robb, G Belcher et al. · PubMed · 1999 · 42 citations

Medicine, Internal Medicine, Inflammation +12

Iloprost improves femoro-distal graft flow after a single bolus injection

N C Hickey, CP Shearman, M C Crowson et al. · European Journal of Vascular Surgery · 1991 · 24 citations

Medicine, Orthopedic Surgery, Surgery +7